Ongphiphadhanakul B, Rajatanavin R, Chanprasertyothin S, Piaseu N, Chailurkit L, Komindr S, Bunnag P, Puavilai G
Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Metabolism. 1999 May;48(5):564-7. doi: 10.1016/s0026-0495(99)90051-3.
A Trp64Arg mutation in the beta3-adrenergic receptor gene has been implicated in the pathophysiology of non-insulin-dependent diabetes mellitus and obesity. However, the findings have been controversial due to the use of different populations and different methods for the estimation of body fat. In the present study, the prevalence of Trp64Arg mutation of the beta3-adrenergic receptor gene was determined and its relation to body fat as assessed by dual-energy x-ray absorptiometry (DEXA) was evaluated in Thai men and women. The effect on insulin sensitivity as assessed by the serum insulin to glucose ratio was also examined. The subjects were 76 men and 135 women aged 20 to 80 years. Body fat and its regional distribution were assessed by DEXA. Mutation in the beta3-adrenergic receptor gene was determined by polymerase chain reaction (PCR)-restriction fragment length polymorphism. Data are expressed as the mean +/- SEM. Fifty-nine subjects (28.0%) had the Trp64Arg mutation in the beta3-adrenergic receptor gene; 54 (25.6%) were heterozygotes and five (2.4%) were homozygotes. The gene frequency of Trp64Arg mutation was 15.2% in these subjects. In women, Trp64Arg mutation was not associated with the difference in total body fat (Trp/Arg or Arg/Arg, 19.4 +/- 1.0 kg; Trp/Trp, 19.2 +/- 0.6 kg) or percent body fat (Trp/Arg or Arg/Arg, 34.6% +/- 1.2%; Trp/Trp, 34.3% +/- 0.6%). In contrast to the findings in women, men with Trp64Arg mutation had lower total body fat after controlling for age (Trp/Arg or Arg/Arg, 13.2 +/- 1.1 kg; Trp/Trp, 15.8 +/- 0.7 kg; P < .05). However, no difference was found in percent body fat (Trp/Arg or Arg/Arg, 20.9% +/- 1.3%; Trp/Trp, 23.3% +/- 0.7%). No difference in the fasting insulin resistance index (FIRI) was found between subjects with and without Trp64Arg mutation. The data suggest that Trp64Arg mutation of the beta3-adrenergic receptor is common in Thais and appears to exert effects on total body fat but not percent body fat in men. Trp64Arg mutation is not associated with insulin resistance as assessed by the FIRI in Thais.
β3 - 肾上腺素能受体基因中的色氨酸64精氨酸(Trp64Arg)突变与非胰岛素依赖型糖尿病和肥胖症的病理生理机制有关。然而,由于研究使用了不同的人群以及评估体脂的方法不同,研究结果一直存在争议。在本研究中,我们测定了泰国男性和女性中β3 - 肾上腺素能受体基因Trp64Arg突变的患病率,并评估了其与通过双能X线吸收法(DEXA)测定的体脂之间的关系。我们还研究了该突变对通过血清胰岛素与葡萄糖比值评估的胰岛素敏感性的影响。研究对象为76名年龄在20至80岁之间的男性和135名女性。通过DEXA评估体脂及其区域分布。通过聚合酶链反应(PCR)- 限制性片段长度多态性确定β3 - 肾上腺素能受体基因中的突变。数据以平均值±标准误表示。59名受试者(28.0%)在β3 - 肾上腺素能受体基因中存在Trp64Arg突变;54名(25.6%)为杂合子,5名(2.4%)为纯合子。这些受试者中Trp64Arg突变的基因频率为15.2%。在女性中,Trp64Arg突变与总体脂差异无关(Trp/Arg或Arg/Arg组,19.4±1.0 kg;Trp/Trp组,19.2±0.6 kg)或体脂百分比差异无关(Trp/Arg或Arg/Arg组,34.6%±1.2%;Trp/Trp组,34.3%±0.6%)。与女性的研究结果相反,在控制年龄后,携带Trp64Arg突变的男性总体脂较低(Trp/Arg或Arg/Arg组,13.2±1.1 kg;Trp/Trp组,15.8±0.7 kg;P < 0.05)。然而,体脂百分比没有差异(Trp/Arg或Arg/Arg组,20.9%±1.3%;Trp/Trp组,23.